December 2017 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, dated 6 November 2015 and the 2016/17 Invitation to Tender, dated 3 November 2016.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/pharmacode(external link)) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2015/16 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2019

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand
(Supplier)
Date of subsidy change Sole Subsidised Supply date
Tamsulosin hydrochloride Cap 400 mcg,
100 cap blister pack*
$13.51 $11.25 Tamsulosin-Rex
(Rex Medical Ltd)
1 July 2018 1 October 2018

* Note: Tamsulosin hydrochloride was initially notified in error as a bottle pack instead of the correct blister pack.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand
(Supplier)
Date of subsidy change Hospital Supply Status date
Tamsulosin hydrochloride Cap 400 mcg,
100 cap blister pack*
$13.51 $11.25 Tamsulosin-Rex
(Rex Medical Ltd)
1 July 2018 1 September 2018

* Note: Tamsulosin hydrochloride was initially notified in error as a bottle pack instead of the correct blister pack.

2016/17 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2020

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

3. Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Lamivudine Tab 100 mg,
28 bottle pack
$6.00 $4.20 Zetlam
(Mylan)
1 May 2018 1 July 2018 1 October 2018 Zeffix
(GSK)
Thiamine hydrochloride Tab 50 mg,
100 tablet, bottle pack
$5.62 $4.89 Max Health
(Max Health)
1 September 2018 1 November 2018 1 February 2019 Apo-Thiamine
(Apotex)
Zinc and castor oil* Oint 500 g,
tub 500 g
$5.95 $4.25 Boucher
(Boucher and Muir NZ Limited)
1 May 2018 1 July 2018 1 October 2018 Multichem
(Multichem)
Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Sole Supply Brand
(Supplier)
Date of listing/
subsidy change
for tender
winning brand
Date of reference
pricing of other
listed brands
Sole Subsidised Supply date
(and delisting of other listed
brands)
Brand (Supplier) affected by reference pricing and
delisting

* Note presentation description change from zinc and castor oil oint BP to zinc and castor oil oint from 1 February 2018.

4. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand
(Supplier)
Date of subsidy change Sole Subsidised Supply date
Ondansetron Tab disp 4 mg,
10 blister pack
$1.00 $0.95 Ondansetron ODT-DRLA*
(Dr Reddy’s)
1 February 2018 1 May 2018
Tab disp 8 mg,
10 blister pack
$1.50 $1.43 Ondansetron ODT-DRLA
(Dr Reddy’s)
1 February 2018 1 May 2018

* Note brand name change from Dr Reddy’s Ondansetron to Ondansetron ODT-DRLA from 1 February 2018.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

5. Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Lamivudine Tab 100 mg,
28 bottle pack
$6.00 $4.20 Zetlam
(Mylan New Zealand Ltd)
1% 1 May 2018 1 July 2018 Zeffix
(GSK)
Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Hospital Supply Brand
(Supplier)
DV Limit Listing date Hospital Supply Status date Brand (Supplier) affected by
delisting

6. Tenders awarded to listed pharmaceuticals where no brand is listed

The decisions were as follows:

Chemical name Presentation;
Pack size and type

Pack price
Hospital Supply Brand (Supplier) DV Limit Listing date Hospital Supply Status date
Thiamine hydrochloride Tab 50 mg,
100 tablet, bottle pack
$4.89 Max Health
(Max Health)
1% 1 September 2018 1 November 2018
Zinc and castor oil Oint, tub 500 g $4.25 Boucher
(Boucher and Muir NZ Limited)
1% 1 May 2018 1 July 2018

7. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand
(Supplier)
DV Limit Date of subsidy change Sole Subsidised Supply date
Ondansetron Tab disp 4 mg,
10 blister pack
$1.00 $0.95 Ondansetron ODT-DRLA*
(Dr Reddy’s)
1% 1 February 2018 1 April 2018
Tab disp 8 mg, 10 blister pack $1.50 $1.43 Ondansetron ODT-DRLA
(Dr Reddy’s)
1% 1 February 2018 1 April 2018

* Note brand name change from Dr Reddy’s Ondansetron to Ondansetron ODT-DRLA from 1 February 2018.

Tender declines – Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2016/17 Invitation to Tender dated 3 November 2016.

Chemical name Line item
Albendazole Tab 200 mg
Lamivudine Oral liq 5 mg per mL
Zinc and castor oil Oint BP (pack size greater than 30 g)
Zolmitriptan Nasal spray

For products included in the 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.